Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 6.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Pancreas Transplant Alone (PTA) Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 415 100.0% 466 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 6 1.4% 2 0.4%
OKT3 4 1.0% 15 3.2%
Thymoglobulin 248 59.8% 163 35.0%
Zenapax 4 1.0% 50 10.7%
Simulect 7 1.7% 21 4.5%
Campath 112 27.0% 57 12.2%
Rituximab 33 8.0% 6 1.3%
No Induction Drug Reported 48 11.6% 180 38.6%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.